awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35051746-300D9A50-E37A-4BE7-8BC1-43CD08E32FCC
Q35051746-300D9A50-E37A-4BE7-8BC1-43CD08E32FCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051746-300D9A50-E37A-4BE7-8BC1-43CD08E32FCC
Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants.
P2860
Q35051746-300D9A50-E37A-4BE7-8BC1-43CD08E32FCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051746-300D9A50-E37A-4BE7-8BC1-43CD08E32FCC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1d92ca1b2e87970ba762f47c9479b1563c01019
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.